Each episode of AJP Audio brings you an in-depth look at one of the articles featured in that month’s issue of The American Journal of Psychiatry, the official journal of the American Psychiatric Association. Wide-ranging interviews with article authors cover the background, rationale, main findings, and future implications of the research. This podcast is subject to the Terms of Use at ww.psychiatry.org. The views and opinions expressed in this podcast are those of the individual speakers only and do not necessarily represent the views of the American Psychiatric Association, its officers, trustees, or members. The content of this podcast is provided for general informational purposes only and is not intended as, and shall not be understood or construed as, medical or any other type of professional advice nor does it represent any statement of the standard of care. We strongly recommend that any listener follow the advice of physicians directly involved in their care and contact their local emergency response number for any medical emergency. The information within this podcast is provided as-is and is not guaranteed to be correct, complete, or accurate.
https://ajp.psychiatryonline.org/audio
May 2020: Psychedelics and Psychedelic-Assisted Psychotherapy
Executive Editor Michael Roy speaks with Collin Reiff, M.D., and William McDonald, M.D., about their evidence-based summary of the literature on the clinical application of psychedelic drugs in psychiatric disorders.
- How hallucinogens were first used, and some of the key individuals involved in the development of these drugs for medical use [2:23]
- What led to the worry about use of these compounds in the 1960s, and what actions did U.S. policymakers take at the time? [5:35]
- How have opinions changed from the 1960s to the present? [7:01]
- How the authors conducted their research [8:23]
- How the authors determined which drugs to examine [9:38]
- What findings stood out to the authors? [10:28]
- Relationships between the psychological effects and the neurobiology of psychedelic compounds [12:59]
- How ketamine came to be used in clinical care, and what studies have shown about its safety and effectiveness [14:18]
- An outline of psycholytic therapy and psychedelic therapy [17:16]
- What is the potential for these kinds of drugs to be misused? [19:24]
- Conclusions that researchers, clinicians, and other mental health professionals should take away [21:15]
- Recommendations for further research in this area [22:20]
Be sure to let your colleagues know about the podcast, and please rate and review it on Apple Podcasts, Google Play, Stitcher, Spotify, or wherever you listen to it.
Subscribe to the podcast here.
Listen to other podcasts produced by the American Psychiatric Association.
Browse articles online.
Follow the journals of APA Publishing on Twitter.
E-mail us at ajp@psych.org
Image: detail from a 1978 painting by Flournoy Holmes, "Fire Being" (acrylic, 36 in x 42 in). Image provided courtesy of the artist. For this and other works, visit flournoyholmes.com.